November 29, 2018 |
On 16th April we met with a group of leading healthcare professionals and technology experts to learn more about how the new wave of cancer treatments are affecting everyday practice and relationships with patients. Through the discussion, the group identified both challenges and opportunities to lead us in to a world where the potential of latest scientific developments are realised for cancer patients.
If you’re right there at the forefront pushing too hard, some will see you as a maverick, others will see you as an innovator.”
Dr Andy Gaya, BSc, MD, MRCP, MBBS, FRCR
Consultant Clinical Oncologist
SWITCHED ONcology is the latest thought leadership campaign from the award-winning Havas Lynx portfolio. The campaign is designed to combine science, creativity and technology in the delivery of communications that better support healthcare professionals, carers and ultimately patients on their journey with cancer. The campaign provides our partners with deeper insight, smarter ideas and more meaningful innovations, born out of an unprecedented investment into oncology.
This content was provided by Havas Lynx
Company Details
Latest Content from Havas Lynx
“Doctored Truths” exposes the escalating crisis of health misinformation and disinformation, which has been ranked the world’s top short-term risk to the world, for the second year in a row....
Havas Lynx announces the appointment of Ayesha Walawalkar as Chief Strategy Officer, and Talin Apkarian as Havas Lynx Hudson Managing Director.
The global communications group will unite six agencies under one roof in a purpose-built, hybrid workspace at the heart of Manchester’s innovation district
Leading global healthcare communications agency, Havas Lynx , has launched its proprietary data platform, Point.1, to help pharmaceutical companies to gain a deeper understanding of healthcare professionals (HCPs) to drive...
Because if we do not heal the healers, who is going to heal us?
The campaign encourages people who use drugs to do something remarkable – save a life
Havas Lynx Group have launched a children’s book aimed at raising awareness and detecting early signs of dyslexia. Helping to make sure that parents have the support they need whilst...
The Childhood Tumour Trust and Havas Lynx Group have launched a campaign to raise awareness and funds for people living with a rare genetic condition, neurofibromatosis 1 (NF1).
Havas Health & You (HH&Y) have launched the details of a long-term global research project, Behind the Mask, a longitudinal, multi-armed study which focuses on documenting the ongoing evolution of...
Creating meaningful media experiences in pharma
